Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PHAR | Amsterdam | EUR | Real-time | |
PHARMa | BATS Europe | EUR | Delayed | |
PHAR | NASDAQ | USD | Real-time | |
PHGN | Frankfurt | EUR | Delayed |
Period Ending: | 2024 31/03 |
2023 31/12 |
2023 30/09 |
2023 30/06 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 55.59 | 81.22 | 66.7 | 54.9 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 8.39 | 7.12 | 8.3 | 5.72 | ||||||||||||||||||||||||||||||
Gross Profit | 47.2 | 74.1 | 58.4 | 49.17 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 71.9 | 96.51 | 64.8 | 70.68 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | -16.31 | -15.29 | 1.9 | -15.78 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | 20.35 | - | 21.08 | ||||||||||||||||||||||||||||||
Other, Net | 0.312 | -33.61 | -1.4 | -40.25 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | -16.62 | -2.03 | 3.3 | 3.39 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | -4.18 | 1.09 | -0.2 | 2.07 | ||||||||||||||||||||||||||||||
Net Income After Taxes | -12.45 | -3.12 | 3.5 | 1.32 | ||||||||||||||||||||||||||||||
Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | -12.45 | -3.12 | 3.5 | 1.32 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | -12.45 | -3.12 | 3.5 | 1.32 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | -12.45 | -3.12 | 3.5 | 1.32 | ||||||||||||||||||||||||||||||
Dilution Adjustment | - | -0.036 | - | 0.285 | ||||||||||||||||||||||||||||||
Diluted Net Income | -12.45 | -3.09 | 3.5 | 1.03 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 655.16 | 675 | 700 | 672.01 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | -0.019 | -0.005 | 0.005 | 0.002 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | -0.016 | -0.016 | 0.003 | -0.016 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review